European Commission - European Commission authorises third safe and effective vaccine against COVID-19

29 January 2021 |

The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by AstraZeneca, the third COVID-19 vaccine authorised in the EU.

Read more at the link below.

RELATED LINKS

About Us
Profile
Board of Directors
Stakeholder Network
Contact

LOGIN